» Articles » PMID: 36816941

Distinct Respiratory Microbiota Associates with Lung Cancer Clinicopathological Characteristics

Overview
Journal Front Oncol
Specialty Oncology
Date 2023 Feb 23
PMID 36816941
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Commensal microbiota dysbiosis is associated with the development of lung cancer. The current studies about composition of respiratory microbiota in lung cancer patients yielded inconsistent results. This study aimed to examine the association between airway microbiota and lung cancer clinicopathological characteristics.

Methods: Surgically removed lesion tissues from 75 non-small cell lung cancer patients and 7 patients with benign pulmonary diseases were analyzed by 16S rRNA sequencing. Taxonomy, relative abundance, and diversity of respiratory microbiota were compared among lung cancer of different pathology and TNM stages. The effects of antibiotic and cigarette exposure on respiratory microbiota in lung cancer patients were also evaluated.

Results: Bacterial relative abundance and alpha- and beta-diversity analysis of lung microbiota showed significant differences among lung cancer of different pathology and benign pulmonary diseases. At the genus level, the abundance differences of 13 taxa between lung squamous cell carcinoma and lung adenocarcinoma, 63 taxa between lung squamous cell carcinoma and benign pulmonary diseases, and 4 taxa between lung adenocarcinoma and benign pulmonary diseases reached statistical significance. In contrast, diversity differences were not as significant across lung cancer of different stages. No significant differences were observed in tissue taxonomic abundances and diversity at all taxonomic levels between lung cancer patients with and without antibiotic exposure 3 months prior to surgery. For lung adenocarcinoma, respiratory bacterial abundance and diversity at all taxonomic levels did not show significant differences between smokers and non-smokers.

Conclusions: Our results confirm significantly differential respiratory microbiome taxa, abundance, and diversity in lung cancer of different pathology and some stages. Short-term antibiotic application might play a minor role in molding airway microbiota in lung cancer patients. Composition and diversity of respiratory microbiota in lung adenocarcinoma are not affected by cigarette exposure.

Citing Articles

Association between airway microbiota and systemic inflammation markers in non-small cell lung cancer patients.

Huang D, Ren Q, Xie L, Chen Y, Li C, Su X Sci Rep. 2025; 15(1):3539.

PMID: 39875410 PMC: 11775180. DOI: 10.1038/s41598-025-86231-4.


Effect of fermentation on the constituents in the branches and leaves of and non-small cell lung cancer.

Guo X, Wang R, Zhang Z, Zhang H, Wang S, Zhang S Front Pharmacol. 2024; 15:1449498.

PMID: 39508039 PMC: 11538029. DOI: 10.3389/fphar.2024.1449498.


Exploring the potential role of microbiota and metabolites in acute exacerbation of chronic obstructive pulmonary disease.

Shi Y, Yang J, Tian T, Li S, Xie Y Front Microbiol. 2024; 15:1487393.

PMID: 39483760 PMC: 11526122. DOI: 10.3389/fmicb.2024.1487393.


Bioactives of the essential oil from the leaves of Cambess (Myrtaceae) on the effects of tobacco.

de Medeiros J, Rodrigues S, Sakumoto K, Ruiz S, Faria M, Goncalves J Front Pharmacol. 2024; 15:1415659.

PMID: 38910894 PMC: 11190337. DOI: 10.3389/fphar.2024.1415659.


Analyzing the characteristics of respiratory microbiota after the placement of an airway stent for malignant central airway obstruction.

Wang Y, Zhou Y, Huang Y, Li X, Zhang J, Gao Y Microbiol Spectr. 2024; 12(6):e0347223.

PMID: 38747599 PMC: 11237529. DOI: 10.1128/spectrum.03472-23.


References
1.
Kang G, Jung D, Lee Y, Jeon S, Han H, Chong G . Dynamics of Fecal Microbiota with and without Invasive Cervical Cancer and Its Application in Early Diagnosis. Cancers (Basel). 2020; 12(12). PMC: 7766064. DOI: 10.3390/cancers12123800. View

2.
Laudadio I, Fulci V, Palone F, Stronati L, Cucchiara S, Carissimi C . Quantitative Assessment of Shotgun Metagenomics and 16S rDNA Amplicon Sequencing in the Study of Human Gut Microbiome. OMICS. 2018; 22(4):248-254. DOI: 10.1089/omi.2018.0013. View

3.
Kim O, Choi B, Kim D, Kim N, Rho J, Sul W . The microbiome of lung cancer tissue and its association with pathological and clinical parameters. Am J Cancer Res. 2022; 12(5):2350-2362. PMC: 9185621. View

4.
Liu H, Tao L, Zhang J, Zhu Y, Zheng Y, Liu D . Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects. Int J Cancer. 2017; 142(4):769-778. DOI: 10.1002/ijc.31098. View

5.
Dickson R, Huffnagle G . The Lung Microbiome: New Principles for Respiratory Bacteriology in Health and Disease. PLoS Pathog. 2015; 11(7):e1004923. PMC: 4497592. DOI: 10.1371/journal.ppat.1004923. View